$Cartesian Therapeutics (RNAC.US)$ Cartesian plans to hold a...
$Cartesian Therapeutics (RNAC.US)$Cartesian plans to hold a special meeting of stockholders on March 27, 2024 to seek stockholder approval for the conversion of the Company’s Series A Non-Voting Convertible Preferred Stock into the Company’s common stock and a reverse stock split at a ratio in the range of 1 for 20 and 1 for 30.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more